ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

234 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

N/APrimary ImmunodeficiencyPsoriasisAtopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID)300 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Phase 3Atopic Dermatitis

Tralokinumab + TCSPlacebo + TCS

LEO Pharma195 participants72 sites · United States, Belgium, CanadaCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Phase 3Moderate-to-Severe Atopic Dermatitis

RezpegaldesleukinPlacebo

Nektar Therapeutics510 participants1 site · United StatesCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

PALLAS Laser for Skin Diseases

N/AVitiligo VulgarisPsoriasisAlopecia Areata

UVB laser treatment

Szeged University50 participants1 site · HungaryCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Phase 4ITCHAtopic Dermatitis

Roflumilast Cream 0.15%

Integrative Skin Science and Research40 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Phase 4Atopic DermatitisSleep Disturbance

Dupilumab

Northwestern University40 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis

Phase 3Atopic Dermatitis

PG-011GelVehicle

Prime Gene Therapeutics Co., Ltd.472 participants1 site · ChinaCompletes Nov 2024

Compare CT.gov Full analysis →

Recruiting

AI App for Management of Atopic Dermatitis

N/AAtopic DermatitisArtificial Intelligence

Artificial Intelligence assistant decision-making system (AIADMS) App

West China Hospital232 participants1 site · ChinaCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

N/AAtopic DermatitisEczema

Abrocitinib

Pfizer183 participants30 sites · FranceCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment

N/AAtopic Dermatitis

Dupilumab

Sanofi230 participants9 sites · ItalyCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

N/AAtopic DermatitisPsoriasisHidradenitis Suppurativa

SamplingSampling

Assistance Publique - Hôpitaux de Paris830 participants1 site · FranceCompletes Nov 2035

Compare CT.gov Full analysis →

Recruiting

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

N/ASkin InflammationImmunosenescenceInflammation

Lactobacillus casei Shirota (LcS) Probiotic DrinkSkimmed Milk Control Drink

King's College London30 participants1 site · United KingdomCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer

N/AHead and Neck NeoplasmsRadiodermatitis

Boswellia serrata 2% topical cream

Youssef Hashem Hafez60 participants2 sites · EgyptCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Natural History and Genetics of Food Allergy and Related Conditions

N/AFood AllergyLoeys-Dietz SyndromeAtopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID)1,800 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

1–15 of 234

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

234 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

N/APrimary ImmunodeficiencyPsoriasisAtopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID)300 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Phase 3Atopic Dermatitis

Tralokinumab + TCSPlacebo + TCS

LEO Pharma195 participants72 sites · United States, Belgium, CanadaCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

Phase 3Moderate-to-Severe Atopic Dermatitis

RezpegaldesleukinPlacebo

Nektar Therapeutics510 participants1 site · United StatesCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

PALLAS Laser for Skin Diseases

N/AVitiligo VulgarisPsoriasisAlopecia Areata

UVB laser treatment

Szeged University50 participants1 site · HungaryCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118

Phase 1Psoriasis

HS-20118HS-20118 placebo

Jiangsu Hansoh Pharmaceutical Co., Ltd.132 participants9 sites · United States, New ZealandCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Phase 4ITCHAtopic Dermatitis

Roflumilast Cream 0.15%

Integrative Skin Science and Research40 participants1 site · United StatesCompletes Aug 2027

Compare CT.gov Full analysis →

Recruiting

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Phase 4Atopic DermatitisSleep Disturbance

Dupilumab

Northwestern University40 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis

Phase 3Atopic Dermatitis

PG-011GelVehicle

Prime Gene Therapeutics Co., Ltd.472 participants1 site · ChinaCompletes Nov 2024

Compare CT.gov Full analysis →

Recruiting

AI App for Management of Atopic Dermatitis

N/AAtopic DermatitisArtificial Intelligence

Artificial Intelligence assistant decision-making system (AIADMS) App

West China Hospital232 participants1 site · ChinaCompletes Dec 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.

N/AAtopic DermatitisEczema

Abrocitinib

Pfizer183 participants30 sites · FranceCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab Treatment

N/AAtopic Dermatitis

Dupilumab

Sanofi230 participants9 sites · ItalyCompletes Mar 2028

Compare CT.gov Full analysis →

Recruiting

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

N/AAtopic DermatitisPsoriasisHidradenitis Suppurativa

SamplingSampling

Assistance Publique - Hôpitaux de Paris830 participants1 site · FranceCompletes Nov 2035

Compare CT.gov Full analysis →

Recruiting

Skin Inflammation in (Peri)Menopause: A Probiotic Intervention Proof of Concept Trial

N/ASkin InflammationImmunosenescenceInflammation

Lactobacillus casei Shirota (LcS) Probiotic DrinkSkimmed Milk Control Drink

King's College London30 participants1 site · United KingdomCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

Topical Boswellia Serrata 2% to Prevent Radiation Dermatitis in Head and Neck Cancer

N/AHead and Neck NeoplasmsRadiodermatitis

Boswellia serrata 2% topical cream

Youssef Hashem Hafez60 participants2 sites · EgyptCompletes Oct 2027

Compare CT.gov Full analysis →

Recruiting

Natural History and Genetics of Food Allergy and Related Conditions

N/AFood AllergyLoeys-Dietz SyndromeAtopic Dermatitis

National Institute of Allergy and Infectious Diseases (NIAID)1,800 participants1 site · United StatesCompletes Jun 2027

Compare CT.gov Full analysis →

1–15 of 234